• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌脑转移对放射性碘治疗有反应。

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy.

作者信息

Hashimoto Leo, Watanabe Shiro, Majigsuren Mungunkhuyag, Hirata Kenji, Takenaka Junki, Kimura Rina, Ishii Hiroshi, Kudo Kohsuke

机构信息

Department of Nuclear Medicine, Hokkaido University Hospital, Sapporo, Japan.

Department of Diagnostic and Interventional Radiology, Hokkaido University Hospital, Sapporo, Japan.

出版信息

Asia Ocean J Nucl Med Biol. 2025;13(2):208-212. doi: 10.22038/aojnmb.2025.86276.1618.

DOI:10.22038/aojnmb.2025.86276.1618
PMID:40585286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12205132/
Abstract

Brain metastasis (BM) occurs only in about 1% of differentiated thyroid carcinoma (DTC) cases. Although DTC generally has a good prognosis, once BM develops, the mortality rate significantly increases up to 78%. BM is usually treated by surgical resection or external radiotherapy, whereas radioactive iodine therapy (RAIT) using I-131 is much less often chosen because BM often shows poor uptake of I-131. In addition, even in case I-131 accumulates in the BM, RAIT could cause adverse effects such as brain hemorrhage and cerebral edema. We present a case of BM from DTC that showed response to I-131 therapy with no severe adverse effects. The brain lesion was very small and asymptomatic, and was only found after a post-therapy I-131 scintigraphy. There are a few case reports where BM was cured by RAIT with little to no side effects. We theorize that BM that is small in size, asymptomatic and show I-131 accumulation could be successfully treated with RAIT.

摘要

脑转移(BM)仅发生在约1%的分化型甲状腺癌(DTC)病例中。尽管DTC总体预后良好,但一旦发生BM,死亡率会显著上升至78%。BM通常通过手术切除或外照射放疗进行治疗,而使用I - 131的放射性碘治疗(RAIT)则较少被选用,因为BM往往对I - 131摄取不佳。此外,即使I - 131在BM中蓄积,RAIT也可能导致脑出血和脑水肿等不良反应。我们报告一例来自DTC的BM病例,该病例对I - 131治疗有反应且无严重不良反应。脑部病变非常小且无症状,仅在治疗后I - 131闪烁扫描时才被发现。有一些病例报告显示BM通过RAIT治愈且几乎没有副作用。我们推测,体积小、无症状且显示I - 131蓄积的BM可以通过RAIT成功治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/6b9ce8910389/AOJNMB-13-208-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/a5a60f9e2172/AOJNMB-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/3e50dd5a93ba/AOJNMB-13-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/937ecab915f1/AOJNMB-13-208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/6b9ce8910389/AOJNMB-13-208-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/a5a60f9e2172/AOJNMB-13-208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/3e50dd5a93ba/AOJNMB-13-208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/937ecab915f1/AOJNMB-13-208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcbe/12205132/6b9ce8910389/AOJNMB-13-208-g004.jpg

相似文献

1
Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy.分化型甲状腺癌脑转移对放射性碘治疗有反应。
Asia Ocean J Nucl Med Biol. 2025;13(2):208-212. doi: 10.22038/aojnmb.2025.86276.1618.
2
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
3
Antiseptics for burns.烧伤用防腐剂
Cochrane Database Syst Rev. 2017 Jul 12;7(7):CD011821. doi: 10.1002/14651858.CD011821.pub2.
4
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.早期和极早期肝细胞癌的消融和非手术治疗:系统评价和网络荟萃分析。
Health Technol Assess. 2023 Dec;27(29):1-172. doi: 10.3310/GK5221.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Negative pressure wound therapy for surgical wounds healing by primary closure.负压伤口疗法在一期缝合手术伤口愈合中的应用。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD009261. doi: 10.1002/14651858.CD009261.pub7.
9
Antioxidants for female subfertility.用于女性生育力低下的抗氧化剂。
Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3.
10
Brexanolone, zuranolone and related neurosteroid GABA receptor positive allosteric modulators for postnatal depression.用于产后抑郁症的布雷沙诺龙、祖拉诺龙及相关神经甾体GABA受体正变构调节剂。
Cochrane Database Syst Rev. 2025 Jun 26;6(6):CD014624. doi: 10.1002/14651858.CD014624.pub2.

本文引用的文献

1
Screening and treatment of brain metastasis from papillary thyroid carcinoma: a case series.甲状腺乳头状癌脑转移的筛查与治疗:病例系列
Thyroid Res. 2023 Jan 11;16(1):1. doi: 10.1186/s13044-023-00146-8.
2
Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes.分化型甲状腺癌脑转移:患病率、当前治疗方法及治疗结果
J Endocr Soc. 2018 Nov 21;3(2):359-371. doi: 10.1210/js.2018-00241. eCollection 2019 Feb 1.
3
Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer.
晚期、转移性及放射性碘难治性分化型甲状腺癌的治疗进展
Front Endocrinol (Lausanne). 2017 Nov 20;8:312. doi: 10.3389/fendo.2017.00312. eCollection 2017.
4
A rare case of asymptomatic radioiodine-avid renal and brain metastases 20 years after hemi-thyroidectomy for adenomatous goiter.1例罕见的无症状性放射性碘摄取性肾和脑转移瘤,发生于因腺瘤性甲状腺肿行半甲状腺切除术后20年。
Indian J Nucl Med. 2016 Jan-Mar;31(1):42-4. doi: 10.4103/0972-3919.172358.
5
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
6
Cerebral metastases from thyroid carcinoma: complete remission following radioiodine treatment.甲状腺癌脑转移:放射性碘治疗后完全缓解
Dtsch Arztebl Int. 2013 Dec 13;110(50):861-6. doi: 10.3238/arztebl.2013.0861.
7
Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.具有放射性碘摄取远处转移的分化型甲状腺癌的临床结局和分子特征。
J Clin Endocrinol Metab. 2013 May;98(5):E829-36. doi: 10.1210/jc.2012-3933. Epub 2013 Mar 26.
8
Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors.促甲状腺激素(TSH)体外诱导甲状腺癌细胞产生血管内皮生长因子:TSH信号转导及血管生成刺激生长因子的评估
J Clin Endocrinol Metab. 2004 Dec;89(12):6139-45. doi: 10.1210/jc.2004-1260.
9
Brain metastasis from differentiated thyroid cancer in patients treated with radioiodine for bone and lung lesions.接受放射性碘治疗骨和肺部病变的分化型甲状腺癌患者发生脑转移。
Ann Nucl Med. 2000 Apr;14(2):111-4. doi: 10.1007/BF02988589.
10
Prognosis and treatment of brain metastases in thyroid carcinoma.甲状腺癌脑转移的预后与治疗
J Clin Endocrinol Metab. 1997 Nov;82(11):3637-42. doi: 10.1210/jcem.82.11.4386.